后代健康公司获得1300万美元，用于扩展男性生育平台-动脉网

Posterity Health scores $13M to expand male fertility platform

MobiHealthNews 等信源发布 2025-02-18 22:23



可切换为仅中文







Photo: JOSEP M ROVIROSA/Getty I

照片来源：JOSEP M ROVIROSA/Getty I

mages

图像

Male fertility and sexual healthcare company

男性生育能力和性健康公司

Posterity Health

后代健康

has secured $13 million in Series A funding.

已获得1300万美元的A轮融资。

Georgetown Equity Partners led the round with participation from existing investors Distributed Ventures, WVV and FCA Venture Partners and new investors SteelSky Ventures and Scrub Capital.

乔治敦股权合作伙伴公司领投了本轮融资，现有投资者分布式风险投资公司、WVV和FCA风险合作伙伴公司以及新投资者钢铁天空风险投资公司和洗涤资本公司参与其中。

WHAT IT DOES

它有什么作用

Posterity Health, launched in 2021, is a digital male fertility clinic providing access to reproductive urologists who diagnose and treat sexual health and male fertility issues.

Posterity Health成立于2021年，是一家数字男性生育诊所，提供生殖泌尿科医生的访问服务，这些医生诊断和治疗性健康和男性生育问题。

The company offers sperm cryopreservation, in-clinic or in-home fertility testing, low testosterone treatments, supplements, vasectomy and vasectomy reversal.

该公司提供精子冷冻保存、诊所内或家庭生育能力测试、低睾酮治疗、补充剂、输精管切除术及输精管复通手术。

'I've committed my career to male reproductive health because it remains one of the most underserved and poorly understood areas within healthcare,' Pam Pure, CEO and cofounder of Posterity Health, said in a statement.

“我将自己的职业生涯投入到男性生殖健康领域，因为它仍然是医疗保健领域中最服务不足且最不被理解的领域之一，”Posterity Health 的首席执行官兼联合创始人帕姆·普尔在一份声明中说道。

'This funding gives us the opportunity to serve more men and their families, and it also demonstrates that the tide is turning and that men are starting to take a more active role in their own health. I'm proud to be part of that change.'

“这笔资金使我们有机会服务更多的男性及其家庭，同时也表明形势正在转变，男性开始在自己的健康方面扮演更积极的角色。我为能成为这一变化的一部分感到自豪。”

MARKET SNAPSHOT

市场概况

In 2023, Posterity Health

2023年，Posterity Health

announced a partnership

宣布建立合作伙伴关系

with

Mark Cuban Cost Plus Drug Company

马克·库班成本加成药品公司

(

MCCPDC